HeyJChongMDPhD

Physician

Dr. Chong is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4401 Penn Ave
# Aob
Pittsburgh, PA 15224
Phone+1 412-692-7885

Fax+1 412-692-5732

Registry Study of Revcovi Treatment in Patients With ADA-SCID Start of enrollment: 2019 Sep 30
COMPLETED
Roles: Contact, Principal Investigator

PubMed

Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).
Jacqueline A Pongracic, Rémi Gagnon, Gordon Sussman, Dareen Siri, Roxanne C Oriel
The Journal of Allergy and Clinical Immunology. in Practice. 2025-02-27
DNA-binding affinity and specificity determine the phenotypic diversity in BCL11B-related disorders.
Ivana Lessel, Anja Baresic, Ivan K Chinn, Jonathan May, Anu Goenka
American Journal of Human Genetics. 2025-02-06
A novel splice-site mutation in NFKB1 presenting as common variable immunodeficiency and postoperative hyperinflammation responsive to anti-IL-1 therapy.
Taylor Eddens, Jennifer Lue, Jorna Sojati, Michael Tomani, Ozgur Dede
The Journal of Allergy and Clinical Immunology. in Practice. 2024-10-01

Journal Articles

Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children with Peanut Allergy
Todd D Green, David M Fleischer, Hey Chong, R Sharon Chinthrajah, Edwin H Kim, Stacie M Jones, Robert Wood, Bruce J Lanser, Lynda Schneider, Jacqueline A Pongracic, Wa..., JAMA

Allergy Season Plagues Western Pennsylvania, Thanks to Grass, Ragweed, PollutionAugust 13th, 2020
Signs That Your Youngster Might Be at Risk for Food AllergiesNovember 22nd, 2017